Cost-effectiveness of targeted screening for hepatitis C in The Netherlands

Epidemiol Infect. 2012 Jan;140(1):58-69. doi: 10.1017/S0950268811000112. Epub 2011 Feb 16.

Abstract

On account of the serious complications of hepatitis C virus (HCV) infection and the improved treatment possibilities, the need to improve HCV awareness and case-finding is increasingly recognized. To optimize a future national campaign with this objective, three pilot campaigns were executed in three regions in The Netherlands. One campaign was aimed at the general population, a second (similar) campaign was extended with a support programme for primary care and a third campaign was specifically aimed at hard-drug users. Data from the pilot campaigns were used to build a mathematical model to estimate the incremental cost-effectiveness ratio of the different campaigns. The campaign aimed at the general public without support for primary care did not improve case-finding and was therefore not cost-effective. The similar campaign accompanied by additional support for primary care and the campaign aimed at hard-drug users emerged as cost-effective interventions for identification of HCV carriers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Communicable Diseases, Emerging / diagnosis*
  • Communicable Diseases, Emerging / drug therapy
  • Communicable Diseases, Emerging / prevention & control
  • Communicable Diseases, Emerging / virology
  • Cost-Benefit Analysis
  • Drug Users
  • Health Promotion / economics*
  • Hepatitis C / diagnosis*
  • Hepatitis C / drug therapy
  • Hepatitis C / prevention & control
  • Humans
  • Mass Screening / economics*
  • Multivariate Analysis
  • Netherlands
  • Pilot Projects